Date Initiated by Firm | April 08, 2021 |
Create Date | May 07, 2021 |
Recall Status1 |
Terminated 3 on October 26, 2021 |
Recall Number | Z-1540-2021 |
Recall Event ID |
87556 |
Product Classification |
Reagents, 2019-novel coronavirus nucleic acid - Product Code QJR
|
Product | Revogene SARS-CoV-2
Catalog Number: 410700
IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19 |
Code Information |
All lot numbers |
Recalling Firm/ Manufacturer |
Meridian Bioscience Inc 3471 River Hills Dr Cincinnati OH 45244-3023
|
For Additional Information Contact | Chris Ross 800-343-3858 |
Manufacturer Reason for Recall | Emergency Use Application (EUA) application withdrawn as false negative results reported
|
FDA Determined Cause 2 | Under Investigation by firm |
Action | Meridan issued Urgent Medical Device Recall on 4/08/21 to the user level via phone and electronic mailing . Letter states reason for recall, health risk and action to take:
Revogene SARS-CoV-2, Catalog 410700:
Laboratorys should consider evaluating patient test results per laboratory policies and procedures.
Review current inventory and segregate any remaining stock.
Contact Meridian Technical Support 800.343.3858 to obtain a FedEx label to return any remaining unexpired inventory to Meridian Bioscience Inc. Any expired inventory should be destroyed in accordance with facility protocols.
Complete and return the Customer Notification Form. This will indicate receipt of this field correction notice.
Revogene RNA Software Upgrade Kit, Catalog 610240:
Review current inventory and segregate any remaining stock of the RNA Software kit, including the USB.
Contact Meridian Technical Support 800.343.3858 to obtain a FedEx label to return remaining unexpired inventory to Meridian Bioscience, Inc. Any expired inventory should be destroyed in accordance with facility protocols.
Complete and return the Customer Notification Form. This will indicate receipt of this field correction notice.
Actions to Be Taken By Meridian:
Meridian intends to conduct additional validation and bridging studies with the intention of re-submitting an EUA application for its SARS-CoV-2 test on the Revogene platform as soon as possible thereafter.
Contact Information:
If you have any questions, please call Meridian Bioscience Technical Services at 1-800-343-3858, or email at MBI-TechService@meridianbioscience.com. |
Quantity in Commerce | 376 kits of the Revogene SARS-CoV-2 assay |
Distribution | Nationwide |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|